Genetic and epigenetic variations in iPSCs: potential causes and implications for application.

[1]  S. Mitalipov,et al.  Human Embryonic Stem Cells Derived by Somatic Cell Nuclear Transfer , 2013, Cell.

[2]  N. Rodrigues,et al.  Lack of immune response to differentiated cells derived from syngeneic induced pluripotent stem cells. , 2013, Cell stem cell.

[3]  T. Ludwig,et al.  Homologous recombination DNA repair genes play a critical role in reprogramming to a pluripotent state. , 2013, Cell reports.

[4]  A. Nagy,et al.  Genome damage in induced pluripotent stem cells: assessing the mechanisms and their consequences. , 2013, BioEssays : news and reviews in molecular, cellular and developmental biology.

[5]  Bradley E. Bernstein,et al.  Genome-wide Chromatin State Transitions Associated with Developmental and Environmental Cues , 2013, Cell.

[6]  H. Schöler,et al.  Analysis of protein coding mutations in hiPSCs and their possible role during somatic cell reprogramming , 2013, Nature Communications.

[7]  Y. Hoki,et al.  Negligible immunogenicity of terminally differentiated cells derived from induced pluripotent or embryonic stem cells , 2013, Nature.

[8]  S. Ramaswamy,et al.  A Molecular Roadmap of Reprogramming Somatic Cells into iPS Cells , 2012, Cell.

[9]  Yi Zhang,et al.  Embryonic stem cell and induced pluripotent stem cell: an epigenetic perspective , 2012, Cell Research.

[10]  Hui Yang,et al.  Zscan4 promotes genomic stability during reprogramming and dramatically improves the quality of iPS cells as demonstrated by tetraploid complementation , 2012, Cell Research.

[11]  M. Gerstein,et al.  Somatic copy-number mosaicism in human skin revealed by induced pluripotent stem cells , 2012, Nature.

[12]  Pei-Rong Wang,et al.  Trisomy correction in Down syndrome induced pluripotent stem cells. , 2012, Cell stem cell.

[13]  Alessandra Giorgetti,et al.  Identification of a specific reprogramming-associated epigenetic signature in human induced pluripotent stem cells , 2012, Proceedings of the National Academy of Sciences.

[14]  J. Bradley,et al.  Generating an iPSC bank for HLA-matched tissue transplantation based on known donor and recipient HLA types. , 2012, Cell stem cell.

[15]  J. V. van Deursen,et al.  Reprogramming to Pluripotency Can Conceal Somatic Cell Chromosomal Instability , 2012, PLoS genetics.

[16]  M. Sur,et al.  Molecular signatures of human induced pluripotent stem cells highlight sex differences and cancer genes. , 2012, Cell stem cell.

[17]  A. Wutz.  Epigenetic alterations in human pluripotent stem cells: a tale of two cultures. , 2012, Cell stem cell.

[18]  N. Yamada,et al.  Derivation conditions impact X-inactivation status in female human induced pluripotent stem cells. , 2012, Cell stem cell.

[19]  Christopher A. Miller,et al.  Background mutations in parental cells account for most of the genetic heterogeneity of induced pluripotent stem cells. , 2012, Cell stem cell.

[20]  K. Eggan,et al.  Erosion of dosage compensation impacts human iPSC disease modeling. , 2012, Cell stem cell.

[21]  Julie V. Harness,et al.  Recurrent variations in DNA methylation in human pluripotent stem cells and their differentiated derivatives. , 2012, Cell stem cell.

[22]  Jing Huang,et al.  Distinct regulatory mechanisms and functions for p53-activated and p53-repressed DNA damage response genes in embryonic stem cells. , 2012, Molecular cell.

[23]  N. Benvenisty,et al.  High Prevalence of Evolutionarily Conserved and Species‐Specific Genomic Aberrations in Mouse Pluripotent Stem Cells , 2012, Stem cells.

[24]  P. Park,et al.  Ascorbic acid prevents loss of Dlk1-Dio3 imprinting and facilitates generation of all-iPS cell mice from terminally differentiated B cells , 2012, Nature Genetics.

[25]  Yutao Du,et al.  Low incidence of DNA sequence variation in human induced pluripotent stem cells generated by nonintegrating plasmid expression. , 2012, Cell stem cell.

[26]  George M. Church,et al.  Elevated Coding Mutation Rate During the Reprogramming of Human Somatic Cells into Induced Pluripotent Stem Cells , 2012, Stem cells.

[27]  G. Daley,et al.  The promise of induced pluripotent stem cells in research and therapy , 2012, Nature.

[28]  M. Ko,et al.  Zscan4 transiently reactivates early embryonic genes during the generation of induced pluripotent stem cells , 2012, Scientific Reports.

[29]  Rudolf Jaenisch,et al.  Reprogramming factor stoichiometry influences the epigenetic state and biological properties of induced pluripotent stem cells. , 2011, Cell stem cell.

[30]  Dong Ryul Lee,et al.  Screening ethnically diverse human embryonic stem cells identifies a chromosome 20 minimal amplicon conferring growth advantage , 2011, Nature Biotechnology.

[31]  Andrew P. Feinberg,et al.  Donor cell type can influence the epigenome and differentiation potential of human induced pluripotent stem cells , 2011, Nature Biotechnology.

[32]  Ira M. Hall,et al.  Genome sequencing of mouse induced pluripotent stem cells reveals retroelement stability and infrequent DNA rearrangement during reprogramming. , 2011, Cell stem cell.

[33]  S. Yamanaka,et al.  Immunogenicity of induced pluripotent stem cells. , 2011, Circulation research.

[34]  O. Dreesen,et al.  Unexpected X chromosome skewing during culture and reprogramming of human somatic cells can be alleviated by exogenous telomerase. , 2011, Cell stem cell.

[35]  N. Benvenisty,et al.  Epigenetic memory and preferential lineage-specific differentiation in induced pluripotent stem cells derived from human pancreatic islet beta cells. , 2011, Cell stem cell.

[36]  Yang Xu,et al.  Immunogenicity of induced pluripotent stem cells , 2011, Nature.

[37]  M. Lalande,et al.  Recurrent copy number variations in human induced pluripotent stem cells , 2011, Nature Biotechnology.

[38]  Jun S. Song,et al.  Incomplete DNA methylation underlies a transcriptional memory of somatic cells in human iPS cells , 2011, Nature Cell Biology.

[39]  T. Suda,et al.  Ataxia-telangiectasia mutated (ATM) deficiency decreases reprogramming efficiency and leads to genomic instability in iPS cells. , 2011, Biochemical and biophysical research communications.

[40]  N. Benvenisty,et al.  The tumorigenicity of human embryonic and induced pluripotent stem cells , 2011, Nature Reviews Cancer.

[41]  M. Newton,et al.  Karyotypic abnormalities in human induced pluripotent stem cells and embryonic stem cells , 2011, Nature Biotechnology.

[42]  Riitta Lahesmaa,et al.  Copy number variation and selection during reprogramming to pluripotency , 2011, Nature.

[43]  R. Weksberg,et al.  Isolation of MECP2-null Rett Syndrome patient hiPS cells and isogenic controls through X-chromosome inactivation , 2011, Human molecular genetics.

[44]  R. Stewart,et al.  Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells , 2011, Nature.

[45]  Michael J. Ziller,et al.  Reference Maps of Human ES and iPS Cell Variation Enable High-Throughput Characterization of Pluripotent Cell Lines , 2011, Cell.

[46]  J. Tischfield,et al.  Homologous recombination conserves DNA sequence integrity throughout the cell cycle in embryonic stem cells. , 2011, Stem cells and development.

[47]  E. Kirkness,et al.  Somatic coding mutations in human induced pluripotent stem cells , 2011, Nature.

[48]  Julie V. Harness,et al.  Dynamic changes in the copy number of pluripotency and cell proliferation genes in human ESCs and iPSCs during reprogramming and time in culture. , 2011, Cell stem cell.

[49]  I Wilmut,et al.  Induced pluripotent stem cells: epigenetic memories and practical implications. , 2010, Molecular human reproduction.

[50]  Fred H. Gage,et al.  A Model for Neural Development and Treatment of Rett Syndrome Using Human Induced Pluripotent Stem Cells , 2010, Cell.

[51]  G. Babcock,et al.  Mouse embryonic stem cells, but not somatic cells, predominantly use homologous recombination to repair double-strand DNA breaks. , 2010, Stem cells and development.

[52]  K. Hochedlinger,et al.  Induced pluripotency: history, mechanisms, and applications. , 2010, Genes & development.

[53]  Yoav Mayshar,et al.  Identification and classification of chromosomal aberrations in human induced pluripotent stem cells. , 2010, Cell stem cell.

[54]  Stormy J. Chamberlain,et al.  Induced pluripotent stem cell models of the genomic imprinting disorders Angelman and Prader–Willi syndromes , 2010, Proceedings of the National Academy of Sciences.

[55]  K. Plath,et al.  Female human iPSCs retain an inactive X chromosome. , 2010, Cell stem cell.

[56]  Richard A Young,et al.  Chromatin structure and gene expression programs of human embryonic and induced pluripotent stem cells. , 2010, Cell stem cell.

[57]  M. Pellegrini,et al.  Molecular analyses of human induced pluripotent stem cells and embryonic stem cells. , 2010, Cell stem cell.

[58]  Aaron M. Newman,et al.  Lab-specific gene expression signatures in pluripotent stem cells. , 2010, Cell stem cell.

[59]  K. Hochedlinger,et al.  Cell type of origin influences the molecular and functional properties of mouse induced pluripotent stem cells , 2010, Nature Biotechnology.

[60]  Martin J. Aryee,et al.  Epigenetic memory in induced pluripotent stem cells , 2010, Nature.

[61]  Tomohiro Kono,et al.  Aberrant silencing of imprinted genes on chromosome 12qF1 in mouse induced pluripotent stem cells , 2010, Nature.

[62]  Zachary D. Smith,et al.  Dynamic single-cell imaging of direct reprogramming reveals an early specifying event , 2010, Nature Biotechnology.

[63]  Wei Li,et al.  Activation of the Imprinted Dlk1-Dio3 Region Correlates with Pluripotency Levels of Mouse Stem Cells , 2010, The Journal of Biological Chemistry.

[64]  Kwang-Soo Kim,et al.  Hemangioblastic Derivatives from Human Induced Pluripotent Stem Cells Exhibit Limited Expansion and Early Senescence , 2010, Stem cells.

[65]  James A Thomson,et al.  Neural differentiation of human induced pluripotent stem cells follows developmental principles but with variable potency , 2010, Proceedings of the National Academy of Sciences.

[66]  H. Redl,et al.  Vitamin C enhances the generation of mouse and human induced pluripotent stem cells. , 2010, Cell stem cell.

[67]  Yoav Mayshar,et al.  Clone‐ and Gene‐Specific Aberrations of Parental Imprinting in Human Induced Pluripotent Stem Cells , 2009, Stem cells.

[68]  Jeroen S. van Zon,et al.  Direct cell reprogramming is a stochastic process amenable to acceleration , 2009, Nature.

[69]  C. Pereira,et al.  Senescence impairs successful reprogramming to pluripotent stem cells. , 2009, Genes & development.

[70]  T. Ichisaka,et al.  Hypoxia enhances the generation of induced pluripotent stem cells. , 2009, Cell stem cell.

[71]  Manuel Serrano,et al.  A p53-mediated DNA damage response limits reprogramming to ensure iPS cell genomic integrity , 2009, Nature.

[72]  J. Utikal,et al.  Immortalization eliminates a roadblock during cellular reprogramming into iPS cells , 2009, Nature.

[73]  G. Wahl,et al.  Linking the p53 tumor suppressor pathway to somatic cell reprogramming , 2009, Nature.

[74]  Hideyuki Okano,et al.  Variation in the safety of induced pluripotent stem cell lines , 2009, Nature Biotechnology.

[75]  George Q. Daley,et al.  Disease-Specific Induced Pluripotent Stem Cells , 2008, Cell.

[76]  V. Bohr,et al.  Human Embryonic Stem Cells Have Enhanced Repair of Multiple Forms of DNA Damage , 2008, Stem cells.

[77]  R. Rowntree,et al.  X-chromosome inactivation and epigenetic fluidity in human embryonic stem cells , 2008, Proceedings of the National Academy of Sciences.

[78]  T. Ichisaka,et al.  Generation of germline-competent induced pluripotent stem cells , 2007, Nature.

[79]  J. Utikal,et al.  Directly reprogrammed fibroblasts show global epigenetic remodeling and widespread tissue contribution. , 2007, Cell stem cell.

[80]  P. Andrews,et al.  Adaptation to culture of human embryonic stem cells and oncogenesis in vivo , 2007, Nature Biotechnology.

[81]  Ettore Appella,et al.  p53 induces differentiation of mouse embryonic stem cells by suppressing Nanog expression , 2005, Nature Cell Biology.

[82]  G. Wahl,et al.  ES cells do not activate p53-dependent stress responses and undergo p53-independent apoptosis in response to DNA damage , 1998, Current Biology.

[83]  G. Schatten,et al.  Cell cycle adaptations and maintenance of genomic integrity in embryonic stem cells and induced pluripotent stem cells. , 2011, Results and problems in cell differentiation.

[84]  T. Ichisaka,et al.  GENERATION OF GERMLINECOMPETENT INDUCED PLURIPOTENT STEM CELLS , 2007 .

[85]  J. Thomson,et al.  Recurrent gain of chromosomes 17q and 12 in cultured human embryonic stem cells , 2004, Nature Biotechnology.